Twist Bioscience (TWST) Retained Earnings (2018 - 2026)

Twist Bioscience has disclosed Retained Earnings across 9 years of filings, most recently posting -$1.4 billion for Q1 2026.

• In Q1 2026, Retained Earnings fell 210490.03% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$1.4 billion (down 210490.03% YoY), while the FY2025 annual figure was -$627000.0, up 99.95% from the prior year.
• Retained Earnings eased to -$1.4 billion in Q1 2026, from -$1.4 billion in the prior quarter.
• Over the last five years, Retained Earnings for TWST reached as high as -$609000.0 in Q4 2022 and fell as low as -$1.4 billion in Q1 2026.
• The 5-year median for Retained Earnings is -$1.0 billion (2023), against an average of -$789.3 million.
• Annual changes were most pronounced in 2025 — Retained Earnings surged 99.95% — and 2026, when it tumbled 210490.03%.
• A 5-year view of Retained Earnings shows it stood at -$609000.0 in 2022, then sank by 176614.29% to -$1.1 billion in 2023, then decreased by 18.33% to -$1.3 billion in 2024, then dropped by 6.01% to -$1.4 billion in 2025, then slipped by 3.26% to -$1.4 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$1.4 billion, -$1.4 billion, and -$627000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.